Wikipedia -WSS

Wikipedia

author：leisure time 2025-10-02 20:52:34 - browse：52796

Adam's take main illustration — Molly Ferguson/STAT

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

This week: A chat with Argenx CEO Tim Van Hauwermeiren, and updates on biotech PIPEs, Madrigal Pharmaceuticals, and Annovis Bio.

The Belgian drugmaker Argenx is preparing for a commercial launch this summer that will expand the use of its IgG-lowering antibody Vyvgart to patients with chronic inflammatory demyelinating polyneuropathy, or CIDP, an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

WSS

Generative AI mines health records to identify patients’ social needs

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Designating disabled people as health disparity population is crucial

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Risky weight loss products often used by teens globally, per study

knowledge

Wikipedia

focus

Malaria cases in Florida and Texas: Here’s what you need to know

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

As demand for Covid shots wanes, Moderna seeks its next success

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

Bright Health sells Medicare Advantage business to Molina

The nurse manager staffing crisis is hurting patients

Heart attack and stroke risk calculators need revising

JPM 2024: Verve Therapeutics looks to mainstream genome editing

Novavax promises a turnaround & Lilly roils the obesity market

How I ended up pumping milk in a bathroom stall at JPM 2024

entertainment

Risky weight loss products often used by teens globally, per study

The nurse manager staffing crisis is hurting patients

Risky weight loss products often used by teens globally, per study

New England Journal of Medicine addresses racist history, slavery

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

JPM 2024: Verve Therapeutics looks to mainstream genome editing

focus

leisure time

knowledge

hotspot